Literature DB >> 22237948

Characterization and outcomes of optic nerve gliomas: a population-based analysis.

Mark V Mishra1, David W Andrews, Jon Glass, James J Evans, Adam P Dicker, Xinglei Shen, Yaacov Richard Lawrence.   

Abstract

Optic nerve gliomas (ONG) are rare astrocytic neoplasms. A paucity of literature exists on the epidemiology and outcomes of ONG. Here, we present a series of 445 cases of ONG obtained from the Surveillance, epidemiology and end results (SEER) database. Data on patient and tumor characteristics as well as initial treatment with surgery or radiation were extracted from the SEER Database. Survival rates were calculated using the Kaplan-Meier method. A multivariate analysis was performed to determine independent prognostic factors predicting mortality hazard ratios (HRs) using Cox proportional hazards modeling. The median age range at diagnosis was 5-9 years. Twenty percent of patients were over the age of 20 years. Amongst patients with information available on tumor grade (n = 131), 83% had a low-grade tumors and 17% had a high-grade tumors. Sixteen percent of patients received radiation therapy and 18.4% of patient underwent a sub- or gross total resection. The 5 year overall survival was 96% and 20% for patients with low- and high-grade tumors, respectively. In a multivariate analysis, grade was the only significant predictor of overall survival (HR 29.3, CI: 4.3, 205.4, P < 0.001). Age at diagnosis, receipt of radiation therapy, and extent of surgical resection were not significantly correlated with overall survival. In conclusion, ONG are rare tumors seen predominantly in children. The overall prognosis of high-grade tumors remains poor in all age groups despite multi-modality treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22237948     DOI: 10.1007/s11060-011-0783-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  46 in total

1.  The value of radiation therapy in the management of glioma of the optic nerves and chiasm.

Authors:  J M TAVERAS; L A MOUNT; E H WOOD
Journal:  Radiology       Date:  1956-04       Impact factor: 11.105

2.  Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique.

Authors:  M Fuss; E B Hug; R A Schaefer; M Nevinny-Stickel; D W Miller; J M Slater; J D Slater
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-12-01       Impact factor: 7.038

3.  Optic glioma of childhood. Natural history and rationale for conservative management.

Authors:  W F Hoyt; S A Baghdassarian
Journal:  Br J Ophthalmol       Date:  1969-12       Impact factor: 4.638

4.  A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702).

Authors:  Tore Stokland; Jo-Fen Liu; James W Ironside; David W Ellison; Roger Taylor; Kathryn J Robinson; Susan V Picton; David A Walker
Journal:  Neuro Oncol       Date:  2010-09-22       Impact factor: 12.300

5.  MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis.

Authors:  J F Chateil; C Soussotte; J M Pédespan; M Brun; C Le Manh; F Diard
Journal:  Br J Radiol       Date:  2001-01       Impact factor: 3.039

6.  Daily CT localization for correcting portal errors in the treatment of prostate cancer.

Authors:  J Lattanzi; S McNeely; A Hanlon; I Das; T E Schultheiss; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-15       Impact factor: 7.038

7.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

Authors:  W J Curran; C B Scott; J Horton; J S Nelson; A S Weinstein; A J Fischbach; C H Chang; M Rotman; S O Asbell; R E Krisch
Journal:  J Natl Cancer Inst       Date:  1993-05-05       Impact factor: 13.506

8.  Moyamoya phenomenon after radiation for optic glioma.

Authors:  J R Kestle; H J Hoffman; A R Mock
Journal:  J Neurosurg       Date:  1993-07       Impact factor: 5.115

9.  Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database.

Authors:  Ibrahim Qaddoumi; Iyad Sultan; Amar Gajjar
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

10.  Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function.

Authors:  Thomas E Merchant; Chia-Ho Hua; Hemant Shukla; Xiaofei Ying; Simeon Nill; Uwe Oelfke
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

View more
  13 in total

1.  Can we improve accuracy and reliability of MRI interpretation in children with optic pathway glioma? Proposal for a reproducible imaging classification.

Authors:  Julien Lambron; Josué Rakotonjanahary; Didier Loisel; Eric Frampas; Emilie De Carli; Matthieu Delion; Xavier Rialland; Frédérique Toulgoat
Journal:  Neuroradiology       Date:  2015-10-30       Impact factor: 2.804

2.  Evolution of Care of Orbital Tumors with Radiation Therapy.

Authors:  Myrsini Ioakeim-Ioannidou; Shannon M MacDonald
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-24

3.  Long non-coding RNA GASL1 may inhibit the proliferation of glioma cells by inactivating the TGF-β signaling pathway.

Authors:  Yuhua Hu; Baohua Jiao; Lingyou Chen; Man Wang; Xinwang Han
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

4.  Occurrence of Second Primary Malignancies in Patients With Primary Optic Nerve Gliomas: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Zain Hussain; Jawad Khan; Amir Saeed; Fatma Dihowm
Journal:  Cancer Diagn Progn       Date:  2021-11-03

5.  Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience.

Authors:  Giada Del Baldo; Antonella Cacchione; Vito Andrea Dell'Anna; Pietro Merli; Giovanna Stefania Colafati; Antonio Marrazzo; Sabrina Rossi; Isabella Giovannoni; Sabina Barresi; Annalisa Deodati; Paola Valente; Elisabetta Ferretti; Mara Capece; Angela Mastronuzzi; Andrea Carai
Journal:  Front Surg       Date:  2022-06-16

6.  Limited utility despite accuracy of the national SEER dataset for the study of craniopharyngioma.

Authors:  Todd C Hankinson; Emma C Fields; Michelle R Torok; Brenda L Beaty; Michael H Handler; Nicholas K Foreman; Brent R O'neill; Arthur K Liu
Journal:  J Neurooncol       Date:  2012-08-23       Impact factor: 4.130

7.  Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.

Authors:  Josué Rakotonjanahary; Emilie De Carli; Matthieu Delion; Chantal Kalifa; Jacques Grill; François Doz; Pierre Leblond; Anne-Isabelle Bertozzi; Xavier Rialland
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

8.  Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.

Authors:  Jace P Landry; Kelsey L Schertz; Yi-Ju Chiang; Angela D Bhalla; Min Yi; Emily Z Keung; Christopher P Scally; Barry W Feig; Kelly K Hunt; Christina L Roland; Ashleigh Guadagnolo; Andrew J Bishop; Alexander J Lazar; John M Slopis; Ian E McCutcheon; Keila E Torres
Journal:  JAMA Netw Open       Date:  2021-03-01

9.  A clinical update and radiologic review of pediatric orbital and ocular tumors.

Authors:  Ajay A Rao; John H Naheedy; James Y-Y Chen; Shira L Robbins; Hema L Ramkumar
Journal:  J Oncol       Date:  2013-03-12       Impact factor: 4.375

10.  lncRNA AWPPH promotes the migration and invasion of glioma cells by activating the TGF-β pathway.

Authors:  Bin Dai; Zhiyong Xiao; Beibei Mao; Guangtong Zhu; Hui Huang; Feng Guan; Haiyang Su; Zhenyang Lin; Weicheng Peng; Zhiqiang Hu
Journal:  Oncol Lett       Date:  2019-09-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.